PEN vs. BSX
Compare and contrast key facts about Penumbra, Inc. (PEN) and Boston Scientific Corporation (BSX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PEN or BSX.
Correlation
The correlation between PEN and BSX is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
PEN vs. BSX - Performance Comparison
Loading data...
Key characteristics
PEN:
1.00
BSX:
1.91
PEN:
1.52
BSX:
2.47
PEN:
1.18
BSX:
1.40
PEN:
0.66
BSX:
2.85
PEN:
4.54
BSX:
11.63
PEN:
7.59%
BSX:
3.81%
PEN:
39.71%
BSX:
22.26%
PEN:
-62.64%
BSX:
-89.15%
PEN:
-18.42%
BSX:
-0.13%
Fundamentals
PEN:
$10.66B
BSX:
$155.14B
PEN:
$1.07
BSX:
$1.37
PEN:
257.31
BSX:
76.54
PEN:
-62.27
BSX:
2.58
PEN:
8.60
BSX:
8.84
PEN:
8.79
BSX:
6.98
PEN:
$1.24B
BSX:
$17.55B
PEN:
$787.25M
BSX:
$11.79B
PEN:
$72.64M
BSX:
$4.09B
Returns By Period
The year-to-date returns for both investments are quite close, with PEN having a 18.19% return and BSX slightly higher at 18.72%.
PEN
18.19%
1.04%
18.01%
39.27%
10.43%
N/A
BSX
18.72%
11.33%
21.90%
42.24%
25.01%
19.38%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PEN vs. BSX — Risk-Adjusted Performance Rank
PEN
BSX
PEN vs. BSX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
PEN vs. BSX - Dividend Comparison
Neither PEN nor BSX has paid dividends to shareholders.
Drawdowns
PEN vs. BSX - Drawdown Comparison
The maximum PEN drawdown since its inception was -62.64%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for PEN and BSX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
PEN vs. BSX - Volatility Comparison
Penumbra, Inc. (PEN) has a higher volatility of 10.58% compared to Boston Scientific Corporation (BSX) at 5.81%. This indicates that PEN's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
PEN vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Penumbra, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PEN vs. BSX - Profitability Comparison
PEN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a gross profit of 215.88M and revenue of 324.14M. Therefore, the gross margin over that period was 66.6%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.
PEN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported an operating income of 40.35M and revenue of 324.14M, resulting in an operating margin of 12.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.
PEN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Penumbra, Inc. reported a net income of 39.22M and revenue of 324.14M, resulting in a net margin of 12.1%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.